37
Blackstone Life Sciences VI L.P. updates its Form D — $3.62B sold
Fund raise update · Private equity / buyout · Open-ended · Offering Indefinite · Sold $3.62B · NEW YORK, NY · filed 2025-12-09
3(c)(7) — qualified purchasers
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Earlier and related filings by the same issuer and sponsor. All Blackstone Life Sciences vehicles →
| Omar G. Rehman | Executive Officer |
| Victoria G. Portnoy | Executive Officer |
| Christopher G. Striano | Executive Officer |
| Mathias G. Favetto | Executive Officer |
| Alicia Novak | Executive Officer |
| Robert G. Liptak | Executive Officer |
| Eric G. Liaw | Executive Officer |
| n/a Blackstone Life Sciences Associates VI L.P. | Promoter |
| Nicholas G. Galakatos | Executive Officer |
| n/a BXLS VI L.L.C. | Promoter |
| John G. Finley | Executive Officer |
| Nentcho G. Nentchev | Executive Officer |
| Elsa G. Gelin | Executive Officer |
| Joseph Baratta | Executive Officer |
| Ilan G. Halal | Executive Officer |
| Chris G. Placca | Executive Officer |
Signed by Alicia Novak, Chief Compliance Officer.
Placement agents / sales compensation: UBS Financial Services Inc.; Raymond James & Associates, Inc.; Merrill Lynch, Pierce, Fenner & Smith Incorporated; Morgan Stanley Smith Barney LLC; Raymond James Financial Services Inc.; Compass Group Global Advisors S.A.; iCapital Markets LLC
Relevant to: Fund audit & tax, Fund administrator.
The issuer's phone number and address from the filing are shown to subscribers. See plans.